Australia TGA ARTG recordMedicine administration kit, percutaneous, medicated, single-use
Australia TGA ARTG Registered Device · Sanofi-Aventis Australia Pty Ltd · Sanofi Pasteur · Class IIa · Started October 12, 2018
Good Name: Sanofi-Aventis Australia Pty Ltd - Medicine administration kit, percutaneous, medicated, single-use
- Risk Class
- Class IIa
- Product Type
- Procedure Pack
- ARTG Category
- General
- Start Date
- October 12, 2018
- Effective Date
- October 12, 2018
- Name
- Sanofi Pasteur
- Country
- France
- Address
- 14 Espace Henry Vallee, Lyon, 69007
Adacel (AUST R 297685) is a pertussis vaccine - acellular combined with diphtheria and tetanus toxoids (adsorbed) 0.5mL injection in pre-filled needle-free syringe. Separate needle (either 1 or 2) will be provided in each pack of Adacel syringe for administration.
Access comprehensive regulatory information for Medicine administration kit, percutaneous, medicated, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Sanofi-Aventis Australia Pty Ltd, manufactured by Sanofi Pasteur in France. The device registration started on October 12, 2018.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.